The Heart/X
Jul 14, 2025, 12:30
The Heart: Managing Warfarin-Induced Coagulopathy – New Insights into Handling Prolonged INR Levels
The Heart has published on its official X page:
“Management of Prolonged INR (Warfarin-Induced Coagulopathy)”
Effective management of warfarin-induced coagulopathy, characterized by prolonged INR, is crucial to mitigate bleeding risks. Recent updates highlight evidence-based strategies for timely INR reversal, emphasizing a balance between anticoagulation control and patient safety.
More detailed insights on this topic are available at Hemostasis Today.
American Society of Hematology
American Thrombosis and Hemostasis Network
Anticoagulant complications
Bleeding risk reduction
Coagulopathy guidelines
EHA
Emergency anticoagulation care
Hemostasis and Thrombosis Research Society
Hemostasis management
Hemostasis Today
INR reversal strategies
Prolonged INR management
The Heart
Vitamin K antagonists
Warfarin safety
Warfarin-induced coagulopathy
World Federation of Hemophilia
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action